EarningsQ2 2026 Earnings Report

Oxford BioMedica (OXBDF) Q2 2026 Earnings Report

64 Followers

OXBDF Q2 2026 EPS Results

Actual EPS-$0.40

Consensus EPS-$0.38

Beat/MissMissed by -$0.03

One Year Ago EPS-$0.34

Actual Revenue$105.75M

Expected Revenue$105.95M

Beat/MissMissed by -$205.28K

YoY Revenue Growth+9.04%

QuarterQ2 2026

Date09/22/2026

TimeBefore Open

Conference CallTuesday, September 22, 2026

OXBDF Upcoming Earnings

Oxford BioMedica's next earnings date is estimated for April 15, 2027, based on past reporting schedules.

OXBDF Q2 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Apr 15, 2027	2026 (Q4)	-0.03 / -	-0.072	―
Sep 22, 2026	2026 (Q2)	-0.38 / -0.40	-0.336	-19.69% (-0.07)
Mar 26, 2026	2025 (Q4)	-0.10 / -0.07	-0.102	29.87% (+0.03)
Sep 23, 2025	2025 (Q2)	-0.32 / -0.34	-0.409	17.80% (+0.07)
Apr 09, 2025	2024 (Q4)	-0.10 / -0.10	-1.502	93.21% (+1.40)
Sep 23, 2024	2024 (Q2)	-0.37 / -0.41	-0.658	37.83% (+0.25)
Apr 29, 2024	2023 (Q4)	-0.65 / -1.50	-0.192	-682.07% (-1.31)
Sep 20, 2023	2023 (Q2)	-0.47 / -0.66	-0.362	-82.05% (-0.30)
Apr 25, 2023	2022 (Q4)	-0.09 / -0.19	0.015	-1418.18% (-0.21)
Sep 15, 2022	2022 (Q2)	-0.10 / -0.36	0.283	-227.57% (-0.64)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed